STAT+: Bill Ackman’s bold plan to transform brain research
Reported by STAT News · all stories from statnews.com
Editorial digest
Investor Bill Ackman has announced an ambitious initiative to reshape neurological science. The report examines his strategic vision for accelerating discoveries across neurological studies and cognitive healthcare innovation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom11/4/2026
STAT+: The biotech startups skipping AI for drug discovery
Some emerging biotechnology firms are choosing to bypass artificial intelligence tools when developing new pharmaceuticals.
- Trusted health newsroom11/8/2026
STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype
Recent setbacks in cardiovascular medication trials highlight the need for caution regarding artificial intelligence promises in medicine.
- Trusted health newsroom10/20/2026
STAT+: OpenEvidence’s JAMA paper leaves open questions
A recent journal publication regarding OpenEvidence still leaves several unanswered questions in medical technology.
- Trusted health newsroom10/14/2026
STAT+: The startup chasing ‘general biological intelligence’
A new company is pursuing advanced biological AI capabilities.
- Trusted health newsroom10/13/2026
STAT+: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE
An assessment of Google's diagnostic AI chatbot, AMIE, has provided key findings.
- Trusted health newsroom9/30/2026
STAT+: HHS announces new efforts to speed up, expand clinical trials with AI
HHS initiatives aim to accelerate and broaden clinical research with artificial intelligence.